BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190517
DTEND;VALUE=DATE:20190620
DTSTAMP:20260729T170254
CREATED:20190517T193504Z
LAST-MODIFIED:20190517T193504Z
UID:21254-1558051200-1560988799@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:The Polyak laboratory focuses on translational studies with potential clinical impact. Her laboratory is an integral part of the Breast Cancer Research program in Dana-Farber Cancer Institute (DFCI) and Dana-Farber/Harvard Cancer Center (DF/HCC)\, and two of the strategic centers in DFCI: the Center for Cancer Genome Discovery (CCGC) and Center for Functional Cancer Epigenetics (CFCE). Research in the laboratory is dedicated to the molecular analysis of human breast cancer. The overall goal is to dissect breast tumor evolution and use this information to improve the clinical management of breast cancer patients. The three main areas of interests are: (1) how to accurately predict breast cancer risk and prevent breast cancer initiation or progression from in situ to invasive disease\, (2) better understand drivers of tumor evolution with special emphasis on metastatic progression and therapeutic resistance\, and (3) novel therapeutic targets in breast cancer with particular focus on “bad” cancers such as triple negative breast cancer and inflammatory breast cancer. All of the studies start with analyzing samples from breast cancer patients (or normal healthy for the risk studies)\, formulate hypotheses based on our observations\, use experimental models to test these\, and then translate back our findings into clinical care. \n\n\n\n\nResponsibilities\n\n\n\n\nPerform RNA-seq and ChIP-seq analysis\n\n\nPerform cell and molecular biology research\nPerform a variety of basic assays\, and experiments in breast cancer research\nEffectively work with research technicians and cross-functional project teams\n\n\nMaintain accurate records\, write reports\, and prepare/give presentations\n\n  \n\n\n\nQualifications\n\n\n\nPosition requires a minimum of a Ph.D. in the field of study in Molecular Biology\, Biochemistry\, or Genetics.
URL:https://ces.b2sg.org/event/df-17may19/
LOCATION:Dana-Farber Cancer Institute\, 450 Brookline Avenue\, Boston\, MA\, 02215\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Dana-Farber.jpg
END:VEVENT
END:VCALENDAR